Evidence map›Paper›PMID 36342152›Full record

ArticleAntimicrobial agents and chemotherapy2022

Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.

Michael Thy, Saïk Urien, Frantz Foissac, Naïm Bouazza, Inès Gana, Emmanuelle Bille, Agathe Béranger, Julie Toubiana, Romain Berthaud, Fabrice Lesage and 4 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Piperacillin Pharmacokinetics in a Pediatric Patient With Primary Hyperoxaluria Receiving High-Dose Continuous Dialysis Post Liver-Kidney Transplant.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Michael ThyService de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Université Paris Cité, Paris, France.ORCID 0000-0001-9366-505X
Saïk UrienUnité de recherche Clinique-Centre d'Investigation Clinique, Hôpital Cochin-Necker, AP-HP, Paris, France.
Frantz FoissacEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
Naïm BouazzaEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
Inès GanaUnité de recherche Clinique-Centre d'Investigation Clinique, Hôpital Cochin-Necker, AP-HP, Paris, France.
Emmanuelle BilleService de microbiologie, Hôpital Necker Enfants-Malades, AP-HP, Université Paris Cité, Paris, France.
Agathe BérangerEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.ORCID 0000-0002-9751-8249
Julie ToubianaService de Pédiatrie Générale et Infectieuse, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Paris, France.ORCID 0000-0001-9561-669X
Romain BerthaudService de Néphrologie Pédiatrique, Centre de Référence MARHEA, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Paris, France.
Fabrice LesageService de réanimation et surveillance continue médicochirurgicales, Hôpital Necker Enfants-Malades, AP-HP, Université Paris Cité, Paris, France.
Sylvain RenolleauService de réanimation et surveillance continue médicochirurgicales, Hôpital Necker Enfants-Malades, AP-HP, Université Paris Cité, Paris, France.
Jean-Marc TréluyerEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
Sihem BenaboudEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
Mehdi OualhaEA7323, Evaluation des thérapeutiques et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
Hôpital Necker-Enfants Malades · FRUniversité Paris Cité · FRHôpital Cochin · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to develop a piperacillin population pharmacokinetic (PK) model in critically ill children receiving continuous renal replacement therapy (CRRT) and to optimize dosing regimens. The piperacillin plasma concentration was quantified by high-performance liquid chromatography. Piperacillin PK was investigated using a nonlinear mixed-effect modeling approach. Monte Carlo simulations were performed to compute the optimal scheme of administration according to the target of 100% interdose interval time in which concentration is one to four times above the MIC (100% fT > 1 to 4× MIC). A total of 32 children with a median (interquartile range [IQR]) postnatal age of 2 years (0 to 11), body weight (BW) of 15 kg (6 to 38), and receiving CRRT were included. Concentration-time courses were best described by a one-compartment model with first-order elimination. BW and residual diuresis (

Indexed as

Continuous Renal Replacement TherapyPiperacillinAnti-Bacterial AgentsChildChild, PreschoolCritical IllnessHumansPiperacillin, Tazobactam Drug CombinationRenal Replacement TherapyAnti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug Combinationchildrencritical careintensive carepediatric drug therapypediatric infectious diseasepharmacologypiperacillinpopulation pharmacokineticsrenal failurerenal replacement therapy

Identifiers

PMID36342152
PMCPMC9764994
OpenAlexW4308366422

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.